オバトダイオリド:薬学的な活動とメカニズムにおける最近の進歩
Yingying Zhou1, Jianguo Zhang1, Qingqing Xia1
1Department of Laboratory Medicine, Taizhou First People's Hospital, Taizhou, China.
Planta medica
|September 5, 2025
まとめ
アニソメレス・インディカの化合物であるオバトディオライドは 重要な細胞経路を標的として 抗癌および抗線維剤として有望であることが示されています そのメカニズムをさらに研究することで 新しい治療の応用が可能になります
科学分野:
- 自然製品化学
- 薬理学について
- 薬剤化学
背景:
- オバトディオライドは,アニソメレス・インディカから派生したマクロサイクリック・ディターペノイドである.
- 最近の研究では 薬理学的な作用の幅が広く示されています
研究 の 目的:
- オボトディオライドの発見,合成,および薬理学的作用をレビューする.
- 治療効果の背後にある分子メカニズムを解明する
- 臨床応用の可能性を評価する
主な方法:
- オボトディオライドに関する既存の研究の文献レビュー.
- 信号伝達経路への影響を詳細に分析した研究
- 抗がん性,抗線維性,抗ウイルス性,抗細菌性,抗炎症性に関する研究の検討.
主要な成果:
- Ovatodiolideは,NF-κB/MMP-9,JAK2/STAT3,PI3K/AKT/mTOR,およびWnt/β-cateninのような経路を調節することにより,重要な抗腫瘍活性を示しています.
- 癌の幹細胞を効果的に攻撃する
- 抗線維作用は,TGF-β経路の抑制とグルコース-6- リン酸脱水素酶の抑制によって媒介される.
- 抗ウイルス,抗菌,抗炎症作用がある.
結論:
- オバトダイオライドは様々な薬学的特性を有し,治療的な応用が可能である.
- その分子メカニズムを理解することは 臨床使用を進めるために不可欠です
- オバトダイオライドは薬の開発に有望な候補である.
関連する概念動画
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.5K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.5K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
820
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
820
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
01:24Principles of Drug Action
6.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.6K
01:28Cholinergic Antagonists: Pharmacological Actions
1.2K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.2K
01:26Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K